请输入您要查询的百科知识:

 

词条 Yaakov Nahmias
释义

  1. Career

  2. Research

  3. Personal life

  4. References

  5. External links

{{Orphan|date=June 2013}}{{Infobox scientist
| name = Yaakov Nahmias
| image = http://www.rappaport-prize.org.il/RappaportPrize/UploadFiles/pgallery/2015726142144.jpg
| caption = Yaakov Nahmias
| birth_date = Apr, 1974
| birth_place = Tel Aviv, Israel
| nationality = Israeli
| residence = Israel, United States
| field = Liver Biology, Systems Biology, Biomedical Engineering
| work_institution = Hebrew University of Jerusalem, Harvard Medical School
| alma_mater = Technion – Israel Institute of Technology, University of Minnesota
| doctoral_advisor = David Odde
| awards = NIH Research Scientist Development Award (K01), 2008; Golda Meir Fellowship, 2009; Marie Curie Reintegration Grant, 2010; European Research Council Starting Grant, 2011; Rappaport Prize for Biomedical Sciences, 2014; European Research Council Consolidator Grant, 2016;
|
| footnotes =
}}

Yaakov "Koby" Nahmias is an Israeli biomedical engineer and entrepreneur. Nahmias is a professor at the Hebrew University of Jerusalem and an affiliated member of the NIH-funded BioMEMS Resource Center at Massachusetts General Hospital.

Nahmias is the founding director of the Alexander Grass Center for Bioengineering. He is a co-founder of Israel’s BioDesign Medical Innovation program, recently listed as a major reason for Boston Scientific's continued investment in Israel.[1]

In 2014, he won the Rappaport Prize for Biomedical Sciences for his “groundbreaking work on liver tissue engineering” and the “development of nanotechnology therapies for the treatment of diabetes”.[2][3]

Nahmias edited a book titled [https://www.amazon.com/Microdevices-Biology-Medicine-Methods-Bioengineering/dp/1596934042%20 Microdevices in Biology and Medicine], and is currently serving as a technology consultant for L’Oreal,[4] and a member of the European Research Council panel for applied life sciences and biotechnology.[5]

Career

Yaakov Nahmias received his B.Sc. in Chemical Engineering and Biology from the Technion – Israel Institute of Technology, graduating Magna Cum Laude.[6] He completed his PhD at the University of Minnesota with David Odde,[7] and his postdoctoral training at Harvard Medical School with Martin Yarmush. In 2006, he became an independent investigator at Harvard Medical School, winning a NIH Research Scientist Development Award (K01).[8] Nahmias moved to the Hebrew University of Jerusalem in 2009, where he won two major European Research Council (ERC) Starting and Consolidator Grants,[9][10] and founded the Alexander Grass Center for Bioengineering. In 2010, Nahmias became a Golda Meir fellow and a member of the ERC Starting Grant panel on applied life sciences and biotechnology (LS9).[11] In 2012, Nahmias together with Chaim Lotan, established BioDesign Israel, a multi-disciplinary program in medical innovation taught at the Hebrew University of Jerusalem and its affiliated Hadassah Medical Center.[12] Spin offs from the BioDesign program raised over $1.2 million in investments, won national awards and were featured in MassChallenge.

Research

Nahmias is a liver biologist and a biomedical engineer who took part in the development of Lodamin, the first oral, broad-spectrum angiogenesis inhibitor [13] and the first decellularization of an intact liver for transplantation.[14] His own work showed that the Hepatitis C Virus (HCV) assembles on VLDL and that its production is blocked by the grapefruit flavonoid naringenin.[15] Nahmias' work is leading to a growing understanding of the role of diet and nutrition on liver metabolism,[16][17] including the first demonstration that gut bacteria affect liver development after birth,[18] and explaining the toxic affects of acetaminophen using liver-on-chip technology.[19]

Personal life

Nahmias is married to Michal Haimov, an attorney specializing in real estate and securities. The couple met at the University of Minnesota, are currently living in Eden Prairie and have three children, Maya, Oren, and Neta.

References

1. ^{{citation| url = http://www.globes.co.il/news/article.aspx?did=1001058860| title = Boston Scientific "Interesting in increasing activity in Israel"| date =August 2015| publisher =Globes, Israel Business Arena| location =Israel| accessdate =15 Oct 2015}}
2. ^{{citation| url = http://www.timesofisrael.com/biotech-breakthroughs-net-two-scientists-rappaport-prize/| title = Biotech breakthroughs net two scientists Rappaport prize| date =February 2014| publisher = Times of Israel| location =Israel| accessdate =15 Oct 2015}}
3. ^{{citation| url = http://new.huji.ac.il/en/article/19752| title = 2014 Rappaport Prize for Excellence in Biomedical Research Awarded to Hebrew University's Dr. Yaakov Nahmias| date =February 2014| publisher = The Hebrew University of Jerusalem| location =Israel| accessdate =15 Oct 2015}}
4. ^{{citation| url = https://www.linkedin.com/pub/yaakov-nahmias/11/4b5/926| title =LinkedIN Profile| date =April 2015| accessdate =15 Oct 2015}}
5. ^{{citation| url =http://www.ukro.ac.uk/erc/stg/Documents/110714_stg11_panel_members.pdf| title =ERC Panel Members 2011| date =July 2011| publisher =European Research Council| location =Belgium| accessdate =2 June 2013}}
6. ^{{citation| url =http://www.cs.huji.ac.il/~ynahmias/Microliver_Laboratory/About_Us.html| title =Yaakov Nahmias CV| date =August 2012| publisher =Hebrew University| location =Israel| accessdate =28 May 2013}}
7. ^{{citation| url =http://oddelab.umn.edu/people.html| title =Odde Lab Website| date =April 2013| publisher =University of Minnesota| location =United States| accessdate =2 June 2013}}
8. ^{{citation| url =http://projectreporter.nih.gov/project_info_description.cfm?projectnumber=1K01DK080241-01| title =NIH Project 1K01DK080241| date =June 2013| publisher =National Institute of Health| location =United States| accessdate =2 June 2013}}
9. ^{{citation| url =http://cordis.europa.eu/search/index.cfm?fuseaction=proj.document&PJ_RCN=10833397| title =ERC Project TMIHCV| date =April 2010| publisher =CORDIS Europa| location =Belgium| accessdate =2 June 2013}}
10. ^{{citation| url =http://cordis.europa.eu/project/rcn/204731_es.html| title =ERC Project OCLD| date =October 2016| publisher =CORDIS Europa| location =Belgium|access-date=13 October 2016}}
11. ^{{citation| url =http://www.ukro.ac.uk/erc/stg/Documents/110714_stg11_panel_members.pdf| title =ERC Panel Members 2011| date =July 2011| publisher =European Research Council| location =Belgium| accessdate =2 June 2013}}
12. ^{{citation| url =http://cbsh.cs.huji.ac.il/Center_for_Bioengineering/Biodesign.html| title =Jerusalem BioDesign: Medical Innovation| date =Nov 2012| publisher =The Hebrew University of Jerusalem| location =Israel| accessdate =2 June 2013}}
13. ^{{citation| url =https://www.sciencedaily.com/releases/2008/06/080630114209.htm| title =New Oral Angiogenesis Inhibitor Offers Potential Nontoxic Therapy For A Wide Range Of Cancers| date =June 2008| publisher =Science Daily| location =United States | accessdate =2 June 2013}}
14. ^{{citation| url =http://f1000.com/prime/4916957| title =Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix| date =Sep 2010| publisher =Faculty of 10,000 Medicine| location =United States | accessdate =2 June 2013}}
15. ^{{citation| url =http://jama.jamanetwork.com/article.aspx?articleid=181726| title =Grapefruit Compound Battles Hepatitis C| date =April 2008| publisher =Journal of the American Medical Association | location =United States | accessdate =2 June 2013}}
16. ^{{citation| url =http://pubs.rsc.org/en/content/articlelanding/2013/fo/c3fo60063g/unauth| title =Flavonoids as dietary regulators of nuclear receptor activity| date =April 2013| publisher =Royal Society of Chemistry | location =Britain | accessdate =2 June 2013}}
17. ^{{citation| url =http://www.dailymail.co.uk/news/article-3141218/The-wonders-grapefruit-diet-squashed-Celebrity-fad-hep-lose-weight-eat-40-once.html| title =The wonders of the grapefruit diet have been squashed!| date =June 2015| publisher =Daily Mail | location =Britain | accessdate =10 Oct 2015}}
18. ^{{citation| url = http://www.haaretz.com/life/science-medicine/1.668651| title = Israeli Scientist Has Baby, Realizes How to Grow Viable Liver Cells in the Lab| date =July 2015| publisher =Haaretz | location =Israel | accessdate =15 Oct 2015}}
19. ^{{citation| url = http://www.upi.com/Health_News/2015/08/17/Researchers-Acetaminophen-toxic-at-lower-levels-than-thought/8721439825741/| title = Researchers: Acetaminophen toxic at lower levels than thought| date =August 2015| publisher =UPI | location =Jerusalem | accessdate =15 Oct 2015}}

External links

  • MicroLiver Technologies Laboratory
  • [https://www.ncbi.nlm.nih.gov/pubmed?term=Yaakov%20Nahmias PubMed citations]
{{DEFAULTSORT:Nahmias, Yaakov}}

5 : Living people|University of Minnesota alumni|Harvard Medical School faculty|Hebrew University of Jerusalem faculty|1974 births

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/11/13 9:31:24